Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Forte Biosciences, Inc. | toca-ex311_7.htm |
| 10-K - 10-K - Forte Biosciences, Inc. | toca-10k_20191231.htm |
| EX-31.2 - EX-31.2 - Forte Biosciences, Inc. | toca-ex312_6.htm |
| EX-23.1 - EX-23.1 - Forte Biosciences, Inc. | toca-ex231_9.htm |
| EX-10.21 - EX-10.21 - Forte Biosciences, Inc. | toca-ex1021_197.htm |
| EX-10.20 - EX-10.20 - Forte Biosciences, Inc. | toca-ex1020_196.htm |
| EX-10.18 - EX-10.18 - Forte Biosciences, Inc. | toca-ex1018_540.htm |
| EX-10.12 - EX-10.12 - Forte Biosciences, Inc. | toca-ex1012_412.htm |
| EX-10.11 - EX-10.11 - Forte Biosciences, Inc. | toca-ex1011_383.htm |
| EX-10.10 - EX-10.10 - Forte Biosciences, Inc. | toca-ex1010_384.htm |
| EX-4.2 - EX-4.2 - Forte Biosciences, Inc. | toca-ex42_195.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Tocagen Inc. (the “Company”) on Form 10-K for the period ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), to which this Certification is attached as Exhibit 32.1, I certify, pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: February 27, 2020 |
|
By: |
/s/ MARTIN J. DUVALL |
|
|
|
|
Martin J. Duvall |
|
|
|
|
Chief Executive Officer (Principal Executive Officer) |
|
|
|
|
|
|
Date: February 27, 2020 |
|
By: |
/s/ MARK FOLETTA |
|
|
|
|
Mark Foletta |
|
|
|
|
Chief Financial Officer (Principal Financial Officer) |
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Tocagen Inc. under the Securities Act of 1933, as amended, or the Exchange Act, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.